CXCL10 and renal cell carcinoma: CD8+ T cells (p = 0.002), dendritic cells (p = 0.016), CXCL9 expression (p = 0.048), CXCL10 expression (p = 0.046), CXCL11 expression (p = 0.004), and CXCL13 expression (p = 0) were significantly associated with the clinical outcome of RCC patients (Table 4).